Abstract
Background: Targeted precision cryotherapy has emerged as a novel approach in aesthetic dermatology, offering enhanced precision and safety during procedures. This study evaluated the efficacy and safety of a poly‐D,L‐lactic acid–hyaluronic acid (PDLLA–HA) hybrid filler administered using a TargetCool device to improve facial skin quality. Materials and Methods: A prospective controlled study was conducted in 20 Korean women with melasma, hyperpigmentation, or dark spots. One hemiface was treated with PDLLA–HA using a precision cryotherapy device, while the contralateral side received the same formulation via a microneedle roller. Skin parameters, including melanin content, dermal density, pore volume, pore density, pore count, and redness, were assessed at baseline, during treatment, and 1 month after the final session. Visual grading, patient‐reported outcomes, and safety evaluations were also performed. Results: Cryotherapy‐assisted delivery demonstrated significantly greater improvements than microneedling in melanin reduction (31.28% vs. 23.40%), dermal density (30.07% vs. 17.37%), and pore‐related parameters, including volume (53.43% vs. 33.61%) and density (57.80% vs. 21.62%). Redness was significantly reduced on the cryotherapy‐treated side. Participant satisfaction was high, with consistent improvements in skin texture and overall appearance. No adverse events were observed. Conclusion: Precision cryotherapy‐assisted delivery of PDLLA + HA provides superior efficacy and favorable safety compared with conventional application methods. This approach may enhance transdermal delivery while minimizing tissue trauma, representing a promising strategy for advanced aesthetic dermatologic treatments.

This publication has 21 references indexed in Scilit: